Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-29 6:19 pm Purchase | 2021-04-29 | 13G | Galera Therapeutics, Inc. GRTX | HIRSCHMAN ORIN | 1,736,322 11.000% | 1,736,322 (New Position) | Filing History |
| 2021-04-16 4:07 pm Sale | 2021-04-12 | 13G | Nuvve Holding Corp. NVVE | HIRSCHMAN ORIN | 1,795 11.000% | -2,005 (-52.77%) | Filing History |
| 2021-04-06 06:39 am Purchase | 2021-03-19 | 13G | Nuvve Holding Corp. NVVE | HIRSCHMAN ORIN | 3,800 11.000% | 3,800 (New Position) | Filing History |
| 2021-03-25 6:28 pm Sale | 2021-03-19 | 13G | Evoke Pharma, Inc. EVOK | HIRSCHMAN ORIN | 9,952 4.400% | -1,853 (-15.70%) | Filing History |
| 2021-03-17 4:10 pm Sale | 2021-03-12 | 13G | NLS Pharmaceutics AG NLSP | HIRSCHMAN ORIN | 14,430 4.900% | -8,570 (-37.26%) | Filing History |
| 2021-03-17 4:06 pm Sale | 2021-03-15 | 13G | Acer Therapeutics Inc. ACER | HIRSCHMAN ORIN | 0 0.000% | -982,446 (Position Closed) | Filing History |
| 2021-02-22 07:18 am Purchase | 2021-02-16 | 13G | Adamas Pharmaceuticals, Inc. ADMS | HIRSCHMAN ORIN | 1,611,313 11.000% | 1,611,313 (New Position) | Filing History |
| 2021-02-11 7:15 pm Sale | 2021-01-04 | 13G | Salarius Pharmaceuticals, Inc. SLRX | HIRSCHMAN ORIN | 5,833 4.990% | -254 (-4.17%) | Filing History |
| 2021-02-11 6:25 pm Sale | 2021-02-09 | 13G | Cyclo Therapeutics, Inc. CYTH | HIRSCHMAN ORIN | 209,383 4.990% | -208,617 (-49.91%) | Filing History |
| 2021-02-10 4:26 pm Purchase | 2020-12-31 | 13G | NanoVibronix, Inc. NAOV | HIRSCHMAN ORIN | 38,573 3.900% | 17,090 (+79.55%) | Filing History |
| 2021-02-10 4:23 pm Purchase | 2020-12-31 | 13G | Myomo, Inc. MYO | HIRSCHMAN ORIN | 433,569 9.500% | 17,510 (+4.21%) | Filing History |
| 2021-02-10 4:21 pm Purchase | 2020-12-31 | 13G | LightPath Technologies, Inc. LPTH | HIRSCHMAN ORIN | 1,854,324 7.100% | 20,193 (+1.10%) | Filing History |
| 2021-02-10 4:18 pm Purchase | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | HIRSCHMAN ORIN | 501,025 11.000% | 28,000 (+5.92%) | Filing History |
| 2021-02-10 4:13 pm Purchase | 2020-12-31 | 13G | Acer Therapeutics Inc. ACER | HIRSCHMAN ORIN | 982,446 11.000% | 982,446 (New Position) | Filing History |
| 2021-02-10 2:36 pm Purchase | 2020-12-31 | 13G | EMCORE Corporation EMKR | HIRSCHMAN ORIN | 231,036 7.800% | 33,135 (+16.74%) | Filing History |
| 2021-02-09 5:06 pm Sale | 2021-02-09 | 13G | Energy Focus, Inc. EFOI | HIRSCHMAN ORIN | 0 0.000% | -42,857 (Position Closed) | Filing History |
| 2021-02-09 4:58 pm Purchase | 2021-02-03 | 13G | Ideal Power Inc. IPWR | HIRSCHMAN ORIN | 246,457 4.500% | 46,581 (+23.30%) | Filing History |
| 2021-02-04 06:30 am Purchase | 2021-01-29 | 13G | NLS Pharmaceutics AG NLSP | HIRSCHMAN ORIN | 23,000 7.800% | 23,000 (New Position) | Filing History |
| 2021-02-04 06:30 am Sale | 2021-01-29 | 13G | Ocean Bio-Chem, Inc. OBCI | HIRSCHMAN ORIN | 383,159 4.040% | -335,397 (-46.68%) | Filing History |
| 2021-01-28 07:49 am Sale | 2021-01-21 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 328,358 4.760% | -170,439 (-34.17%) | Filing History |